Forward Pharma (FWP) Reports Q4 Loss of $0.25/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Forward Pharma (FWP) PT Lowered to $22 at Jefferies; Reiterates Hold
April 19, 2017 9:10 AM EDTJefferies lowered its price target on Forward Pharma (NASDAQ: FWP) to $22.00 (from $24.00) while maintaining a Hold rating. FWP reported a 4Q16 EPS of $0.20 vs estimates of ($0.41). The difference was the recognition of a $21.3M deferred tax benefit that FWP expects to utilize in 2017... More
